Skip to content

Coya Therapeutics, Inc.

COYA· NasdaqCore metricsCIK 1835022

Pharmaceutical preparations552 peers

Last sale
Nov 12, 2026 · +0.47%
Market cap
$75.77M
23.46M shares
Filings
232
$234.13K
Q3 2026+123.6% FY25 yoy
-$10.62M
Q3 2026N/M FY25 yoy
-$10.95M
Q3 2026N/M FY25 yoy
—
—
—
-$0.45
Q3 2026N/M FY25 yoy
$35.80M
Q3 2026+22.1% FY25 yoy
$75.77M
—
16.2×
2.3×
—
—

Twelve months to Sep 30, 2026 · derived

Price

$3.2346.70%$2.83past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$7.95MFY 2025
$7.95M0FY 2022FY 2023FY 2024FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$7,945,753reported
FY 20242024-12-31$3,554,061reported
FY 20232023-12-31$6,002,206reported
FY 20222022-12-31$0reported

Pharmaceutical preparations

Coya Therapeutics, Inc. is the 176th largest of the 553 covered companies the SEC files under this code, by revenue. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Coya Therapeutics, Inc. · CIK 1835022 · Engraved from SEC EDGAR